ESCC
Clinical trials for ESCC explained in plain language.
Never miss a new study
Get alerted when new ESCC trials appear
Sign up with your email to follow new studies for ESCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Pre-Surgery combo aims to wipe out esophageal cancer cells
Disease control Not yet recruitingThis study is testing a new combination of immunotherapy and chemotherapy drugs given before surgery for a type of esophageal cancer. The goal is to see if this pre-surgery treatment can completely eliminate cancer cells in the removed tumor and improve long-term results. It will…
Matched conditions: ESCC
Phase: NA • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New combo therapy trial offers hope for elderly esophageal cancer patients
Disease control Not yet recruitingThis study is testing whether combining a cancer drug called TAS-102 with radiation therapy is safe and effective for older adults with advanced esophageal cancer. The first part finds the safest dose, and the second part checks how well that dose works to control the cancer. The…
Matched conditions: ESCC
Phase: PHASE1, PHASE2 • Sponsor: Qianfoshan Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Double-Punch immunotherapy trial aims to shrink tumors before surgery
Disease control Not yet recruitingThis study is testing a new combination treatment for people with a type of esophageal cancer that can be surgically removed. Before surgery, patients will receive a two-part immunotherapy drug along with a chemotherapy drug to try to shrink the tumor. The main goal is to see if …
Matched conditions: ESCC
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC